{
    "info": {
        "nct_id": "NCT06542250",
        "official_title": "A Modular Phase I/II Open-label Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With Relapsed or Refractory B-Cell Malignancies (TITANium)",
        "inclusion_criteria": "* ≥18 years of age;\n* Histologically documented CD20+ mature B-cell neoplasm\n\n  * Large B-cell lymphoma\n  * Follicular lymphoma\n  * Mantle cell lymphoma\n  * Chronic lymphocytic leukemia\n  * Small lymphocytic lymphoma\n* Relapsed, progressive and/or refractory disease following at least 2 prior lines of therapy;\n* ECOG performance status of ≤ 2 (< 2 in EU countries).\n\nThe above is a summary, other inclusion criteria details may apply.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Any neoplasm histology not specified in the IC section;\n* Active CNS involvement in lymphoma;\n* CNS pathology including but not limited to any history of seizure disorder/epilepsy;\n* Prior allogeneic HSCT within 180 days, prior autologous HSCT within 90 days, or cell therapy within 90 days of start of therapy;\n* History of Grade ≥ 3 CRS or Grade ≥ 3 ICANS;\n* Active and uncontrolled infections;\n* Unresolved AEs ≥2 Grade due to prior anticancer therapies, with some exceptions\n\nThe above is a summary, other exclusion criteria details may apply.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* ≥18 years of age;",
            "criterions": [
                {
                    "exact_snippets": "≥18 years of age",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Large B-cell lymphoma",
            "criterions": [
                {
                    "exact_snippets": "Large B-cell lymphoma",
                    "criterion": "Large B-cell lymphoma",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Follicular lymphoma",
            "criterions": [
                {
                    "exact_snippets": "Follicular lymphoma",
                    "criterion": "follicular lymphoma",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Histologically documented CD20+ mature B-cell neoplasm",
            "criterions": [
                {
                    "exact_snippets": "Histologically documented",
                    "criterion": "histological documentation",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "CD20+",
                    "criterion": "CD20 expression",
                    "requirements": [
                        {
                            "requirement_type": "expression",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "mature B-cell neoplasm",
                    "criterion": "mature B-cell neoplasm",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Mantle cell lymphoma",
            "criterions": [
                {
                    "exact_snippets": "Mantle cell lymphoma",
                    "criterion": "mantle cell lymphoma",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Chronic lymphocytic leukemia",
            "criterions": [
                {
                    "exact_snippets": "Chronic lymphocytic leukemia",
                    "criterion": "chronic lymphocytic leukemia",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Small lymphocytic lymphoma",
            "criterions": [
                {
                    "exact_snippets": "Small lymphocytic lymphoma",
                    "criterion": "small lymphocytic lymphoma",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Relapsed, progressive and/or refractory disease following at least 2 prior lines of therapy;",
            "criterions": [
                {
                    "exact_snippets": "Relapsed, progressive and/or refractory disease",
                    "criterion": "disease status",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": [
                                "relapsed",
                                "progressive",
                                "refractory"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "following at least 2 prior lines of therapy",
                    "criterion": "number of prior lines of therapy",
                    "requirements": [
                        {
                            "requirement_type": "count",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "lines of therapy"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* ECOG performance status of ≤ 2 (< 2 in EU countries).",
            "criterions": [
                {
                    "exact_snippets": "ECOG performance status of ≤ 2 (< 2 in EU countries)",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "score",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": ""
                                    }
                                ]
                            }
                        },
                        {
                            "requirement_type": "score (EU countries)",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<",
                                        "value": 2,
                                        "unit": ""
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "The above is a summary, other inclusion criteria details may apply.",
            "criterions": [
                {
                    "exact_snippets": "The above is a summary, other inclusion criteria details may apply.",
                    "criterion": "other inclusion criteria",
                    "requirements": [
                        {
                            "requirement_type": "applicability",
                            "expected_value": "may apply"
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Active CNS involvement in lymphoma;",
            "criterions": [
                {
                    "exact_snippets": "Active CNS involvement in lymphoma",
                    "criterion": "CNS involvement in lymphoma",
                    "requirements": [
                        {
                            "requirement_type": "activity status",
                            "expected_value": "active"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Unresolved AEs ≥2 Grade due to prior anticancer therapies, with some exceptions",
            "criterions": [
                {
                    "exact_snippets": "Unresolved AEs ≥2 Grade due to prior anticancer therapies",
                    "criterion": "adverse events due to prior anticancer therapies",
                    "requirements": [
                        {
                            "requirement_type": "resolution status",
                            "expected_value": "unresolved"
                        },
                        {
                            "requirement_type": "severity grade",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "Grade"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "The above is a summary, other exclusion criteria details may apply.",
            "criterions": [
                {
                    "exact_snippets": "other exclusion criteria details may apply",
                    "criterion": "other exclusion criteria",
                    "requirements": [
                        {
                            "requirement_type": "applicability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any neoplasm histology not specified in the IC section;",
            "criterions": [
                {
                    "exact_snippets": "Any neoplasm histology not specified in the IC section",
                    "criterion": "neoplasm histology",
                    "requirements": [
                        {
                            "requirement_type": "exclusion",
                            "expected_value": "not specified in the IC section"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Active and uncontrolled infections;",
            "criterions": [
                {
                    "exact_snippets": "Active and uncontrolled infections",
                    "criterion": "infections",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "control_status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* CNS pathology including but not limited to any history of seizure disorder/epilepsy;",
            "criterions": [
                {
                    "exact_snippets": "CNS pathology",
                    "criterion": "CNS pathology",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "any history of seizure disorder/epilepsy",
                    "criterion": "history of seizure disorder or epilepsy",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior allogeneic HSCT within 180 days, prior autologous HSCT within 90 days, or cell therapy within 90 days of start of therapy;",
            "criterions": [
                {
                    "exact_snippets": "Prior allogeneic HSCT within 180 days ... of start of therapy",
                    "criterion": "allogeneic HSCT",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 180,
                                "unit": "days"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "prior autologous HSCT within 90 days ... of start of therapy",
                    "criterion": "autologous HSCT",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 90,
                                "unit": "days"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "cell therapy within 90 days of start of therapy",
                    "criterion": "cell therapy",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 90,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [
        {
            "line": "* History of Grade ≥ 3 CRS or Grade ≥ 3 ICANS;",
            "criterions": [
                {
                    "exact_snippets": "History of Grade ≥ 3 CRS",
                    "criterion": "CRS (Cytokine Release Syndrome)",
                    "requirements": [
                        {
                            "requirement_type": "history of severity grade",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "grade"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "History of Grade ≥ 3 ICANS",
                    "criterion": "ICANS (Immune Effector Cell-Associated Neurotoxicity Syndrome)",
                    "requirements": [
                        {
                            "requirement_type": "history of severity grade",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "grade"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "failed_miscellaneous": []
}